Vulnerabilities

Vulnerability · CVE-2025-4081

Use of entitlement "com.apple.security.cs.disable-library-validation" and lack of launch and library load constraints allows to substitute a legitimate dylib with malicious one.

Published May 29, 2025 · catalog updated May 29, 2025 · Blackmagic Design DaVinci Resolve

Check this week

CVE-2025-4081 is not in CISA KEV. FIRST estimates a 15.00% chance of exploitation in the next 30 days. Check whether you run Blackmagic Design DaVinci Resolve.

Gaps on this record

  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium4.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
15.00%
Remediation
Vendor / distro source
Affected products
vendor Blackmagic Design DaVinci Resolve 0 ≤*.*

Use of entitlement "com.apple.security.cs.disable-library-validation" and lack of launch and library load constraints allows to substitute a legitimate dylib with malicious one. A local attacker with unprivileged access can execute the application with altered dynamic library successfully bypassing Transparency, Consent, and Control (TCC). Acquired resource access is limited to previously granted permissions by the user. Access to other resources beyond granted-permissions requires user interaction with a system prompt asking for permission. This issue affects DaVinci Resolve on macOS in all v

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Blackmagic Design DaVinci Resolve 0 ≤*.*0 ≤*.*

How to fix CVE-2025-4081

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-4081 is not in CISA KEV. FIRST estimates a 15.00% chance of exploitation in the next 30 days. Check whether you run Blackmagic Design DaVinci Resolve.

Which versions are affected?

Compare what you have installed with Blackmagic Design DaVinci Resolve 0 ≤*.* 0 ≤*.*. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 15.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 29, 2025 · EUVD

    Detected

    Use of entitlement "com.apple.security.cs.disable-library-validation" and lack of launch and library load constraints allows to substitute a legitimate dylib with malicious one. A local attacker with unprivileged access can execute the application with altered dynamic library successfully bypassing Transparency, Consent, and Control (TCC). Acquired resource access is limited to previously granted

  2. May 29, 2025 · EUVD

    Updated

    Use of entitlement "com.apple.security.cs.disable-library-validation" and lack of launch and library load constraints allows to substitute a legitimate dylib with malicious one. A local attacker with unprivileged access can execute the application with altered dynamic library successfully bypassing Transparency, Consent, and Control (TCC). Acquired resource access is limited to previously granted

Sources

  • CVE.orgVulnerability recordCVE-2025-4081

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-16379

    Use of entitlement "com.apple.security.cs.disable-library-validation" and lack of launch and library load constraints allows to substitute a legitimate dylib with malicious one. A local attacker with unprivileged access can execute the application with altered dynamic library suc

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog May 29, 2025. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.